1. Home
  2. UIS vs HELP Comparison

UIS vs HELP Comparison

Compare UIS & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unisys Corporation New

UIS

Unisys Corporation New

HOLD

Current Price

$3.53

Market Cap

220.2M

Sector

Technology

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$4.60

Market Cap

214.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UIS
HELP
Founded
1942
N/A
Country
United States
Canada
Employees
N/A
50
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.2M
214.5M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
UIS
HELP
Price
$3.53
$4.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$5.67
$51.50
AVG Volume (30 Days)
1.1M
567.3K
Earning Date
05-05-2026
07-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,950,100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.97
$3.76
52 Week High
$4.98
$8.55

Technical Indicators

Market Signals
Indicator
UIS
HELP
Relative Strength Index (RSI) 47.40 52.71
Support Level $3.51 $4.32
Resistance Level $4.06 $4.75
Average True Range (ATR) 0.30 0.30
MACD -0.10 0.07
Stochastic Oscillator 3.64 85.00

Price Performance

Historical Comparison
UIS
HELP

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. maximum of revenue is from CA&I segment.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: